embody vs ro Weight Loss (2026): Cost, Meds & Insurance Compared

This is general information, not medical advice. GLP-1 medications are prescription-only and require a licensed clinician's evaluation; compounded semaglutide and tirzepatide are not FDA-approved.

"embody vs ro weight loss" is one of the most common comparison searches we see, and it is a slightly unfair fight, because the two companies are selling different things. embody sells one all-inclusive price for compounded medication. ro sells access to brand-name medication through a membership. Here is the snapshot, with every figure taken from our stored, dated checks.

embody is our top-ranked provider on the weight-loss ranking; ro is ranked fifth. The rest of this guide explains why those two positions can both be right for different people, and ends with a head-to-head table and the questions people ask us most about the two.

The simplest way to understand embody GLP-1 vs ro Body is to look at what each company bills you for.

embody: one cash price, compounded medication

embody is a weight-loss-only telehealth program. You complete a roughly five-minute online health qualifier, a licensed medical practitioner reviews your chart (embody says usually within 24 hours, often under five), and if treatment is appropriate a prescription goes to one of the US-based 503A compounding pharmacies embody works with. The medication ships free in one to two days in temperature-controlled, tracked, insured packaging. The monthly price covers the medication, the clinician review, injection supplies and shipping. There is no membership fee, no insurance requirement and no contract; you can cancel at any time, and if a clinician does not approve you for treatment embody refunds you in full.

What you get is compounded semaglutide or compounded tirzepatide, as a weekly injection. embody does not sell brand-name Ozempic, Wegovy or Zepbound, and it does not offer a pill. Support runs through a dedicated nursing team and the patient portal, where dose adjustments are handled; there is no dietician or formal coaching layer. embody is LegitScript-certified, which is an independent certification for online healthcare merchants, and it is operated by Modern Metabolic Medicine, Inc., with prescribing clinicians from OpenLoop Health. The full write-up is in our is embody legit? guide.

ro: a membership plus brand-name medication

ro is one of the longest-established telehealth companies in the US, and weight loss is one program among several. You complete an online medical assessment, a licensed provider reviews it and decides whether treatment is appropriate, and if prescribed the medication is dispensed by ro's own integrated pharmacy and delivered to your home, with dose adjustments handled by the provider over time.

The bill has two parts. The ro Body membership costs $39 for the first month and then $74 to $149 a month depending on the plan, with $74 the rate on a 12-month prepaid plan. It pays for the provider assessment and follow-up, ongoing dose adjustments and the pharmacy service. The medication is billed separately, either through your insurance or at ro's cash price. ro's published weight-loss pricing centers on brand-name medication: the Wegovy pill and pen and the Zepbound KwikPen. Its treatment list in our review also names compounded semaglutide and metabolic support supplements, but the only medication prices we have verified at ro are the brand-name ones, so that is what this guide costs out. ro says some plans may be FSA/HSA eligible, there are no long-term contracts, and the service is not available in every state.

That two-part bill is the single most important thing to understand about ro, because the $39 is for the consultation and membership, not the medicine. Our ro cost guide walks through it line by line.

This is where embody GLP-1 pricing monthly and ro Body membership cost separate. All figures below are the providers' own published prices as we recorded them, with the check date on each.

Line items

Two notes on the embody figures. They are promotional: embody's site showed a pre-Black Friday banner from October 28, 2026 and, on November 3, a countdown to a price increase, with no end date stated. Its published regular prices are $79 for semaglutide and $129 for tirzepatide, which is the number to budget against if the sale ends. And the price is the same at every dose, so stepping up from a starting dose to a maintenance dose does not change what you pay. The ro figures are ro's published pricing from August 2026, restated in our ro cost guide on October 4, 2026; they have an introductory first-month price and a higher ongoing price, and the ongoing price is the one to budget against.

Estimated six-month total, built only from those figures

Six months is long enough to reach a maintenance dose and see whether the medication is working for you, so it is the most useful horizon to compare. This is arithmetic on the stored prices, not a quote.

Read it as two different purchases. For a cash payer open to compounded medication, embody's six months cost less than ro's first two months. For someone whose plan covers Wegovy or Zepbound, ro's membership is the price of being on an FDA-approved brand-name product under medical supervision, and the comparison is your copay plus $74 to $149 against embody's $49. Our stored year-one math for ro's Wegovy pill route comes to roughly $4,300 with the prepaid membership and about $5,100 on the monthly plan; a year of semaglutide at embody is $588. The embody cost guide and the ro cost guide hold each company's figures with their conditions. Prices change, and both are promotional or introductory in part, so confirm on the provider's site before you pay.

The price gap exists because the products differ. embody sells compounded semaglutide and compounded tirzepatide; ro's published pricing is for brand-name Wegovy and Zepbound. The compounded semaglutide vs brand Wegovy question, and the compounded tirzepatide vs Zepbound cost question, are the heart of this comparison.

Brand-name: FDA-approved, with trial results of their own

Wegovy (semaglutide) and Zepbound (tirzepatide) are finished products the FDA has reviewed and approved for chronic weight management. Their results come from large randomized trials. In the Wegovy prescribing information, adults on the 2.4 mg weekly injection lost an average of 14.9% of their body weight over 68 weeks against 2.4% on placebo, the STEP 1 result published in the New England Journal of Medicine in 2021. The Zepbound label reports 20.9% average weight loss at the top 15 mg dose over 72 weeks against 3.1% on placebo. In the one large head-to-head trial, SURMOUNT-5 (NEJM, 2025), 751 adults without diabetes lost 20.2% on tirzepatide and 13.7% on semaglutide at 72 weeks; that trial was open label and run by tirzepatide's maker. All of those figures come from brand-name medication, and more detail is in our GLP-1 weight loss results guide.

ro's brand-name shelf includes the Wegovy pill (oral semaglutide), which matters if you want to avoid injections; our Wegovy pill price guide covers its $149-then-$299 pricing at ro. If you are weighing a GLP-1 injection vs weight loss pill cost, note that at ro the pill's ongoing price ($299) sits in the same range as the pen's ($299 to $399), with the same membership on top of either; GLP-1 pills vs injections sets the two formats side by side.

Compounded: the same active ingredient, a different product, no FDA approval

Compounded semaglutide and tirzepatide are prepared by licensed pharmacies from the active ingredient. The FDA's own compounding questions and answers page (content current September 16, 2025) says plainly that compounded drugs are not FDA-approved, which means the FDA does not verify their safety, effectiveness or quality before they are marketed. There are no clinical trials of the compounded products themselves, so the trial figures above cannot be assumed for them. The FDA's page on concerns with unapproved GLP-1 drugs (content current October 1, 2026) describes adverse event reports, some requiring hospitalization, linked to dosing errors with compounded injectable semaglutide, where patients drew the wrong dose from a multi-dose vial or clinicians miscalculated it. It also lists, as a telehealth red flag, a company that claims its compounded drug is the same as an FDA-approved drug.

That is the trade-off embody's price buys. What makes it a reasonable trade for many people is the pharmacy and the prescriber. embody is LegitScript-certified and fills through US-based 503A compounding pharmacies, meaning state-licensed pharmacies that compound for an individual patient on a prescription. The rules around that got tighter after the shortages ended. On the FDA's page tracking its GLP-1 compounding policy (updated April 1, 2026), the agency records that it declared the tirzepatide injection shortage resolved on December 19, 2024, after re-evaluating an October 2, 2024 decision, and the semaglutide injection shortage resolved on February 21, 2025. Its April 1, 2026 reminder says a 503A pharmacy must compound for an individual patient based on a prescription and must not compound, regularly or in inordinate amounts, products that are "essentially copies" of a commercially available drug, unless a prescriber documents a change that makes a significant difference for that patient. The same update gives an example: semaglutide combined with vitamin B12 may still be treated as essentially a copy when the strengths are within 10% of the commercial products. And it notes that tirzepatide and semaglutide do not currently appear on the 503B bulks list or the FDA's drug shortage list, which restricts the larger outsourcing facilities. Our compounded vs brand-name semaglutide guide goes through what that means in practice.

Flat-rate titration vs dose-tier pricing

One practical difference hides inside the medication question. Both semaglutide and tirzepatide are started low and stepped up over months, and the dose you stay on is the one that produced the trial results. embody prices its compounded medication flat at every dose: $49 or $99 whether you are at the starting dose or the maintenance dose. ro's brand-name prices step up after the introductory period: the Wegovy pill is $149 the first month and $299 after, the Wegovy pen from $199 at intro rates and then $299 to $399, the Zepbound KwikPen from $299 and then $399 to $449. For the pill, our Wegovy pill guide notes that the manufacturer's reported self-pay tiers also rise with dose, so the lowest price belongs to the dose you leave behind. Whichever provider you use, a clinician decides your starting dose and titration plan; neither company lets you choose a dose from a menu, and this guide gives no dosing instructions.

Both providers run a real clinical gate: a licensed clinician reviews your intake and can decline you. The experience around that gate differs.

embody: asynchronous, fast, self-serve

embody's intake is a roughly five-minute online health qualifier. There is no scheduled appointment; a licensed medical practitioner reviews your chart asynchronously, usually within 24 hours and often under five hours by embody's own account. If something needs clarifying you get a message. Once prescribed, orders placed before 2pm Central ship the same day, next-day via UPS, and embody quotes free one-to-two-day delivery in insured, temperature-controlled, tracked packaging. Ongoing care is through the patient portal and a nursing team, with dose adjustments requested and made there. It is a medication-first model: fast, low-friction and deliberately light on live contact. The step-by-step flow, with screenshots of real intake screens, is in our how to start GLP-1 treatment online guide.

ro: online assessment, provider review, in-house pharmacy

ro's stored description is an online medical assessment reviewed by a qualified provider, who decides whether treatment is appropriate, with the medication dispensed by ro's integrated pharmacy and dose adjustments handled by the provider over time. ro's review lists board-certified provider consultations and ongoing care among its features, and notes that wait times can vary during peak periods. We do not hold a published review-time promise or a published delivery window for ro, so we cannot put a number next to embody's 24 hours and 1-2 days; "standard home delivery" is how our battle page records it. ro's size and its in-house pharmacy are real advantages for fulfilment and name recognition, and they are why ro wins the brand and pharmacy category on our embody vs ro battle page.

Labs and what to bring

Neither review in our files states whether labs are required. Across the providers we track, many ask for recent lab work and will order it if you have none, and some accept an attestation, so expect the question and have any recent results to hand. Both intakes will ask for height, weight, medical history, current medications and a government ID, because the prescription is written in your name. Answer honestly: the same answers that could get you declined are the ones that would make a GLP-1 unsafe for you.

Shipping times, side by side

embody's published promise is 1-2 days, cold-chain, free. ro's is home delivery from its own pharmacy without a stored window. Across every provider we track, shipping delays are the most common complaint, and the most common cause is pharmacy backlog rather than carrier time, so order before your current supply runs low whichever provider you choose. Our shipping times comparison sets each published promise next to what customers report.

Everything above in one table. Where we hold no verified fact, the cell says so.

If the table leaves you between the two, the tie-breaker is usually one phone call to your insurer: if your plan covers Wegovy or Zepbound for weight management, ro's route can cost less per month than anything on this site; if it does not, embody's flat price is hard to argue with. Our three highest-ranked online GLP-1 providers are below.

Is embody weight loss legit? Yes, by every signal we can check. embody is LegitScript-certified, an independent certification for online healthcare merchants. It works with US-based 503A compounding pharmacies, meaning state-licensed pharmacies that compound for an individual patient on a prescription. It requires a licensed medical review before any prescription is issued, and that review can and does decline people. Its pricing is published and flat, it refunds in full if you are not approved, and it is operated by a named company, Modern Metabolic Medicine, Inc., with prescribing clinicians from OpenLoop Health. Those are the markers that separate a legitimate telehealth provider from one to avoid, and embody has all of them. Our embody legitimacy guide runs through each.

Is it safe? That is a different question, and the honest answer is that the medication, not the company, carries the risk. embody's products are compounded semaglutide and tirzepatide, which the FDA does not review for safety, effectiveness or quality before sale. The FDA's October 2026 guidance on unapproved GLP-1 drugs documents dosing errors with compounded injectables drawn from multi-dose vials. A reputable provider mitigates that with a licensed pharmacy, a labelled vial with your name, the drug, the strength, the pharmacy's name and a beyond-use date, clear instructions and a nurse line for the first dose; if anything arrives unlabelled, stop and contact the provider. Beyond compounding, GLP-1s themselves have warnings on their labels, including a boxed warning on thyroid C-cell tumours seen in rodents, and warnings on pancreatitis and gallbladder disease, which is why a clinician's review of your history matters and why you should tell them everything.

So: legitimate, yes. Safe, as safe as compounded GLP-1 treatment under a licensed clinician can be, which is a real step below an FDA-approved product with trial data behind it and a real step above anything bought outside the licensed system. For an embody weight loss review covering plans and the full record, see our embody review.

At our verified price index check on November 3, 2026, the cheapest online weight loss injection was compounded semaglutide at welludr for $41 a month, a pre-Black Friday sale price (previously $49) that requires a 12-month plan and is the same at every dose, shipped in three to five business days. The cheapest with no commitment was embody at $49 a month, flat, month to month, shipped in one to two days. For tirzepatide the same two led: $71 at welludr on the 12-month plan and $99 at embody month to month. Both companies' figures were sale prices with no end date stated, and embody's site showed a countdown to a price increase on the day we checked.

Whether $41 or $49 is the better deal depends on the commitment. welludr's $41 saves $96 over a year against embody's $588 but asks for twelve months; embody's $49 is the lowest price you can walk away from after a single month, which matters most in the first weeks when you are finding out whether you tolerate the medication. ro does not compete in this tier: at the stored rates, its cheapest semaglutide route is the Wegovy pill at $149 the first month and $299 after, plus the membership. The live ladder, every provider lowest first with its condition, is on our cheapest GLP-1 online page, and the best online GLP-1 provider in the US overall, on our criteria, is the ranking at the top of this site.

Not in any way we have verified. What our records state is this: ro bills the medication separately from its membership, so where your insurance covers Wegovy the plan can pay its share, and where it does not you pay ro's cash rate, which for the Wegovy pill is $149 the first month and then $299 a month, or from $199 and then $299 to $399 for the pen, on top of the membership. We have no stored statement from ro about absorbing the cost, matching a price, or refunding the membership after a coverage denial, so we cannot tell you that ro covers the gap, and you should not assume it does. Confirm directly with ro before paying the $39 what happens to your membership if your plan denies the medication, and what the ongoing cash price at your maintenance dose would be.

Two things we can say. First, a ro GLP-1 insurance coverage check starts with you, not ro: call the number on your card or search your plan's formulary for "Wegovy" and "Zepbound", and ask whether prior authorization is required; coverage for weight loss alone is much patchier than coverage for diabetes, and many employer plans exclude it. Our GLP-1 with insurance guide explains the formulary, prior authorization and appeals. Second, if coverage is denied, the ro Wegovy cash price without insurance is the number above, and the self-pay backup is compounded semaglutide at $41 to $49 a month, a different, non-FDA-approved product. If brand-name Wegovy is what you want regardless, our Wegovy providers page covers how to get a Wegovy pen online in the US and what each route charges.

Often, yes, but it is a clinician's decision, not a checkout option. Both medications contain semaglutide, so a licensed prescriber at a compounded provider such as embody can review your history, including the dose you are on and how you have tolerated it, and decide whether to prescribe compounded semaglutide and at what dose. Some people switch because insurance coverage ended, some because the cash price at embody is a fraction of a brand-name pen plus membership. The reverse move, from compounded to brand-name Wegovy or Zepbound, is what ro's model is built for, and again a ro provider makes the call.

Three cautions. The compounded product is not the same as Wegovy: same active ingredient, different product, no FDA approval and no trial data of its own, as the FDA's compounding Q&A makes clear. Compounded semaglutide usually arrives as a multi-dose vial you draw from, not a prefilled pen, which is where the dosing-error reports come from, so your first dose deserves the provider's instructions and nurse line. And do not improvise a dose during the switch; tell the new provider exactly what you were taking and when your last dose was, and let them set the plan. Our switching from Ozempic guide covers moving providers or medications without a gap in treatment, and the embody vs ro battle page scores the two providers category by category.

embody vs ro weight loss comes down to two questions. Are you paying cash, and are you comfortable with compounded medication? If yes to both, embody is the stronger offer: $49 a month for compounded semaglutide or $99 for compounded tirzepatide at the November 3, 2026 sale prices, flat at every dose, with the clinician review, supplies and free 1-2 day cold-chain shipping included, a full refund if you are not approved, and no contract. It is our top-ranked provider for exactly that combination. Does your insurance cover Wegovy or Zepbound, or do you want the FDA-approved brand-name product from a large, established platform with its own pharmacy? Then ro is the better fit: a $39-then-$74-to-$149 membership plus the medication, billed separately so your plan can pay for it, and a six-month cash cost that runs about $2,088 to $2,428 for the Wegovy pill if it does not.

Both are legitimate. Both put a licensed clinician between you and the prescription, and that clinician, not this article, decides whether a GLP-1 is right for you and which one. Compounded semaglutide and tirzepatide are not FDA-approved; Wegovy and Zepbound are. Prices are the providers' published rates at our last check and change often, so confirm them at checkout. For the full reviews, see embody and ro; for the legitimacy audits, is embody legit? and is ro legit?. This is general information, not medical advice.